6WMI image
Entry Detail
PDB ID:
6WMI
Title:
ZNF410 zinc fingers 1-5 with 17 mer blunt DNA Oligonucleotide
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2020-04-21
Release Date:
2020-12-09
Method Details:
Experimental Method:
Resolution:
2.75 Å
R-Value Free:
0.19
R-Value Work:
0.15
R-Value Observed:
0.16
Space Group:
P 62
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Zinc finger protein 410
Chain IDs:A, B (auth: D)
Chain Length:155
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polydeoxyribonucleotide
Description:DNA (5'-D(*CP*AP*CP*AP*TP*CP*CP*CP*AP*TP*AP*AP*TP*AP*AP*TP*G)-3')
Chain IDs:C (auth: B), E
Chain Length:17
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polydeoxyribonucleotide
Description:DNA (5'-D(*CP*AP*TP*TP*AP*TP*TP*AP*TP*GP*GP*GP*AP*TP*GP*TP*G)-3')
Chain IDs:D (auth: C), F
Chain Length:17
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression.
Mol.Cell 81 239 254.e8 (2021)
PMID: 33301730 DOI: 10.1016/j.molcel.2020.11.006

Abstact

Metazoan transcription factors typically regulate large numbers of genes. Here we identify via a CRISPR-Cas9 genetic screen ZNF410, a pentadactyl DNA-binding protein that in human erythroid cells directly activates only a single gene, the NuRD component CHD4. Specificity is conveyed by two highly evolutionarily conserved clusters of ZNF410 binding sites near the CHD4 gene with no counterparts elsewhere in the genome. Loss of ZNF410 in adult-type human erythroid cell culture systems and xenotransplantation settings diminishes CHD4 levels and derepresses the fetal hemoglobin genes. While previously known to be silenced by CHD4, the fetal globin genes are exposed here as among the most sensitive to reduced CHD4 levels.. In vitro DNA binding assays and crystallographic studies reveal the ZNF410-DNA binding mode. ZNF410 is a remarkably selective transcriptional activator in erythroid cells, and its perturbation might offer new opportunities for treatment of hemoglobinopathies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures